<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107461">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01755663</url>
  </required_header>
  <id_info>
    <org_study_id>Pharmongkutklao</org_study_id>
    <nct_id>NCT01755663</nct_id>
  </id_info>
  <brief_title>Comparison of Efficacy of Ivabradine Versus Metoprolol</brief_title>
  <acronym>IMAGE</acronym>
  <official_title>Comparison of Efficacy and Safety of Ivabradine Versus Metoprolol for Controlling Heart Rate Prior to 640-Slice Computed Tomographic Angiography in Elective Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Col. Suthee Panichkul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Phramongkutklao College of Medicine and Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Phramongkutklao College of Medicine and Hospital</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ivabradine may be better than Metoprolol for controlling heart rate before Coronary CTA.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Heart rate of patient before CT coronary</measure>
    <time_frame>1 January 2013 to 31 december 2013</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety and side effect of Metoprolol and Ivabradine</measure>
    <time_frame>1 january 2013 to 31 december 2013</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Image quality</measure>
    <time_frame>1 january 2013 to 31 december 2013</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Ivabradine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will recieved ivabradine(5) 1 tab bid pc for 3 day and the day of CT, and recieve placebo of metoprolol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metoprolol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metoprolol (100) 1/2 tab bid pc for 3 day and the day of CT coronary , and placebo of ivabradine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivabradine and Metoprolol</intervention_name>
    <arm_group_label>Ivabradine</arm_group_label>
    <arm_group_label>metoprolol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective patient on scheduled for 640 slices CT coronary at Phramonkutklao hospital

          -  Resting heart rate &gt; 70 BPM

          -  age &gt; 18 years and informed consent

        Exclusion Criteria:

          -  Heart rate &gt; 100 BPM

          -  BP &lt;100/60 mmHg

          -  recent congestive heart failure in 1 mo.

          -  SA node, AV node disease and AF

          -  on permanent pacemaker

          -  CrCL &lt; 15ml/min. , AST or ALT &gt; 3x UNL

          -  on HR reducing drug such as diltiazem, verapamil, digitalis

          -  contraindication for ivabradine or metoprolol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Purich - Surunchupakorn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phramongkutklao College of Medicine and Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Purich Surunchupakorn, M.D.</last_name>
    <phone>081-988-7390</phone>
    <email>winnermd57@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phramonkutklao Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Purich Surunchupakorn, M.D.</last_name>
      <phone>081-988-7390</phone>
      <email>winnermd57@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Purich - Surunchupakorn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>December 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Phramongkutklao College of Medicine and Hospital</investigator_affiliation>
    <investigator_full_name>Col. Suthee Panichkul</investigator_full_name>
    <investigator_title>Col. Suthee Panichkul</investigator_title>
  </responsible_party>
  <keyword>CT coronary</keyword>
  <keyword>Coronary arterial disease</keyword>
  <keyword>ivabradine</keyword>
  <keyword>metoprolol</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Metoprolol</mesh_term>
    <mesh_term>Metoprolol succinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
